DGX Quest Diagnostics

• None no insider bought on the open market
• $240K sold by 1 insider outside a trading plan
• $36.2M sold by 6 insiders under 10b5-1 plans

1. Insider
   Trade
   Value
   Traded, filed
2. J. E. Davis CEO
   Planned sale
   $2.4M 10,000 shares at $242.72 7.6% of stake
   Traded Sep 1 Filed Sep 3
   ↗
3. Michael E Prevoznik SVP & General Counsel
   Planned sale
   $5.5M 22,677 shares at $243.11 38% of stake
   Traded Aug 28 Filed Aug 31
   ↗
4. Mark E Delaney SVP & Chief Commercial Officer
   Planned sale
   $376K 1,600 shares at $235.18 13% of stake
   Traded Jul 28 Filed Jul 29
   ↗
5. Karthik Kuppusamy SVP, Clinical Solutions
   Planned sale
   $1.6M 8,147 shares at $200.00 38% of stake
   Traded Jun 4 Filed Jun 8
   ↗
6. J. E. Davis CEO
   Planned sale
   $1.9M 10,000 shares at $194.14 7% of stake
   Traded Jun 1 Filed Jun 2
   ↗
7. Catherine T. Doherty EVP, Regional Businesses
   Planned sale
   $1.1M 5,558 shares at $206.21 7.6% of stake
   Traded Mar 5 Filed Mar 6
   ↗
8. Michael E Prevoznik SVP & General Counsel
   Planned sale
   $800K 3,878 shares at $206.21 9.4% of stake
   Traded Mar 5 Filed Mar 6
   ↗
9. Patrick Plewman SVP for Diagnostic Services
   Planned sale
   $589K 2,855 shares at $206.21 16% of stake
   Traded Mar 5 Filed Mar 6
   ↗
10. Catherine T. Doherty EVP, Regional Businesses
    Planned sale
    $131K 632 shares at $207.73 0.9% of stake
    Traded Mar 3 Filed Mar 4
    ↗
11. Michael E Prevoznik SVP & General Counsel
    Planned sale
    $109K 526 shares at $207.73 1.4% of stake
    Traded Mar 3 Filed Mar 4
    ↗
12. J. E. Davis CEO
    Planned sale
    $2.1M 10,000 shares at $212.52 7.9% of stake
    Traded Mar 2 Filed Mar 4
    ↗
13. Patrick Plewman SVP for Diagnostic Services
    Planned sale
    $85K 410 shares at $207.73 2.6% of stake
    Traded Mar 3 Filed Mar 4
    ↗
14. Catherine T. Doherty EVP, Regional Businesses
    Planned sale
    $294K 1,433 shares at $204.83 2.1% of stake
    Traded Feb 19 Filed Feb 20
    ↗
15. Patrick Plewman SVP for Diagnostic Services
    Planned sale
    $196K 958 shares at $204.83 5.7% of stake
    Traded Feb 19 Filed Feb 20
    ↗
16. Michael E Prevoznik SVP & General Counsel
    Planned sale
    $228K 1,111 shares at $204.83 2.8% of stake
    Traded Feb 19 Filed Feb 20
    ↗

Also filed in the last 12 months, not counted as buying or selling: 33 stock grants, 32 share withholdings for taxes, 16 other transactions, 8 option exercises, 1 gift, and 1 sale to cover taxes.